Key Highlights
- Needham shifts ARM rating to Buy after two-and-a-half-year Hold, establishes $200 price objective
- Company debuts proprietary AGI CPU processor at “Arm Everywhere” conference
- Meta Platforms becomes inaugural customer for ARM’s new chip technology
- Jefferies increases price objective to $210, projecting $15B revenue boost through FY2031
- Latest quarterly results showed EPS of $0.43 (beating $0.41 estimate) alongside 26.3% revenue growth
Needham analysts initiated a Buy recommendation for Arm Holdings this Wednesday, abandoning their neutral position maintained over the past thirty months and establishing a twelve-month price objective of $200.
Arm Holdings plc American Depositary Shares, ARM
The investment firm highlighted ARM’s strategic evolution in the semiconductor space — implementing higher royalty structures, growing subsystem offerings, and now manufacturing proprietary processors. According to Needham, these initiatives are beginning to deliver measurable results.
The company has demonstrated 26.45% revenue expansion across the trailing twelve-month period. Nineteen Wall Street analysts have adjusted their earnings projections upward for the coming quarter.
A cornerstone of Needham’s upgraded outlook centers on ARM’s semiconductor market entrance via its collaboration with Meta Platforms. Meta has committed as the inaugural customer for ARM’s proprietary AGI CPU, providing the new product with immediate commercial credibility and market validation.
The AGI CPU made its debut at ARM’s “Arm Everywhere” industry event. Following the announcement, Jefferies elevated its price target from $170 to $210, emphasizing the processor’s capability to contribute $15 billion in incremental revenue by the 2031 fiscal year.
Barclays maintained its Overweight stance while increasing its target from $165 to $200. The financial institution emphasized the AGI CPU’s power efficiency characteristics as a competitive edge for artificial intelligence computing tasks.
BofA Securities adjusted its target upward from $140 to $155 while maintaining a Neutral position. Morgan Stanley preserved its Overweight recommendation with a $135 objective, acknowledging ARM’s innovative dual-chiplet CPU architecture tailored for AI cloud applications.
Wall Street Outlook
Current analyst consensus reflects a Moderate Buy rating, with a mean price target of $168.17. This assessment derives from 19 Buy recommendations, 6 Hold ratings, and 1 Sell rating.
ARM’s fifty-day moving average registers at $120.72, while the two-hundred-day average sits at $134.17. The equity trades within a fifty-two-week span of $80.00 to $183.16 and carries a market capitalization approximating $165.95 billion.
The company trades at a P/E multiple of 209. InvestingPro analysis indicates the stock trades above its calculated Fair Value benchmark.
During the latest reporting period, ARM delivered earnings per share of $0.43, surpassing Wall Street’s $0.41 projection. Quarterly revenue reached $1.24 billion, representing 26.3% year-over-year expansion and marginally exceeding the $1.23 billion analyst consensus.
Forward Outlook
ARM provided Q4 FY2026 guidance targeting $0.54 to $0.62 earnings per share. The analyst community collectively projects full-year EPS of $0.90.
Needham emphasized the emergence of agentic artificial intelligence and the expanding importance of CPUs within AI data center infrastructure as sustained growth drivers supporting ARM’s strategic positioning.
The AGI CPU targets agentic AI applications, incorporating a multi-core, energy-optimized architecture. Industry analysts observe the processor will require comprehensive software and hardware ecosystem development to challenge established competitors such as Nvidia, Intel, and AMD.
Susquehanna elevated ARM from Neutral to Positive in January, setting a $150 target. Mizuho reduced its target from $190 to $160 in February while preserving an Outperform rating.
Institutional investors currently hold 7.53% of outstanding shares.
